BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24122170)

  • 21. Transient Receptor Potential Cation Channel Subfamily M Member 8 channels mediate the anti-inflammatory effects of eucalyptol.
    Caceres AI; Liu B; Jabba SV; Achanta S; Morris JB; Jordt SE
    Br J Pharmacol; 2017 May; 174(9):867-879. PubMed ID: 28240768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etodolac activates and desensitizes transient receptor potential ankyrin 1.
    Wang S; Dai Y; Kogure Y; Yamamoto S; Zhang W; Noguchi K
    J Neurosci Res; 2013 Dec; 91(12):1591-8. PubMed ID: 24027177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a ligand binding site in the human transient receptor potential ankyrin 1 pore.
    Klement G; Eisele L; Malinowsky D; Nolting A; Svensson M; Terp G; Weigelt D; Dabrowski M
    Biophys J; 2013 Feb; 104(4):798-806. PubMed ID: 23442958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.
    Nassini R; Fusi C; Materazzi S; Coppi E; Tuccinardi T; Marone IM; De Logu F; Preti D; Tonello R; Chiarugi A; Patacchini R; Geppetti P; Benemei S
    Br J Pharmacol; 2015 Jul; 172(13):3397-411. PubMed ID: 25765567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for promiscuous action of monoterpenes on TRP channels.
    Nguyen THD; Itoh SG; Okumura H; Tominaga M
    Commun Biol; 2021 Mar; 4(1):293. PubMed ID: 33674682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of transient receptor potential A1 channel in algesic and analgesic actions of the organic compound limonene.
    Kaimoto T; Hatakeyama Y; Takahashi K; Imagawa T; Tominaga M; Ohta T
    Eur J Pain; 2016 Aug; 20(7):1155-65. PubMed ID: 27030509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural biology: Pain-sensing TRPA1 channel resolved.
    Clapham DE
    Nature; 2015 Apr; 520(7548):439-41. PubMed ID: 25855290
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure of the TRPA1 ion channel suggests regulatory mechanisms.
    Paulsen CE; Armache JP; Gao Y; Cheng Y; Julius D
    Nature; 2015 Apr; 520(7548):511-7. PubMed ID: 25855297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pore-domain of TRPA1 mediates the inhibitory effect of the antagonist 6-methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole.
    Moldenhauer H; Latorre R; Grandl J
    PLoS One; 2014; 9(9):e106776. PubMed ID: 25181545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of transient receptor potential ankyrin-1 (TRPA1) in lung cells by wood smoke particulate material.
    Shapiro D; Deering-Rice CE; Romero EG; Hughen RW; Light AR; Veranth JM; Reilly CA
    Chem Res Toxicol; 2013 May; 26(5):750-8. PubMed ID: 23541125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perception of specific trigeminal chemosensory agonists.
    Frasnelli J; Albrecht J; Bryant B; Lundström JN
    Neuroscience; 2011 Aug; 189():377-83. PubMed ID: 21575683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TRPA1 channel in migraine mechanism and treatment.
    Benemei S; Fusi C; Trevisan G; Geppetti P
    Br J Pharmacol; 2014 May; 171(10):2552-67. PubMed ID: 24206166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels.
    Bang S; Yoo S; Yang TJ; Cho H; Hwang SW
    Pain; 2011 May; 152(5):1156-1164. PubMed ID: 21353389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of transient receptor potential ankyrin 1 by eugenol.
    Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
    Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRPA1 antagonists as potential analgesic drugs.
    Andrade EL; Meotti FC; Calixto JB
    Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the chemosensing transient receptor potential channel A1 (TRPA1) by alkylating agents.
    Stenger B; Zehfuss F; Mückter H; Schmidt A; Balszuweit F; Schäfer E; Büch T; Gudermann T; Thiermann H; Steinritz D
    Arch Toxicol; 2015 Sep; 89(9):1631-43. PubMed ID: 25395009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TRPA1 channel in inflammatory and neuropathic pain and migraine.
    Nassini R; Materazzi S; Benemei S; Geppetti P
    Rev Physiol Biochem Pharmacol; 2014; 167():1-43. PubMed ID: 24668446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural modeling and patch-clamp analysis of pain-related mutation TRPA1-N855S reveal inter-subunit salt bridges stabilizing the channel open state.
    Zíma V; Witschas K; Hynkova A; Zímová L; Barvík I; Vlachova V
    Neuropharmacology; 2015 Jun; 93():294-307. PubMed ID: 25724085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRPA1 is differentially modulated by the amphipathic molecules trinitrophenol and chlorpromazine.
    Hill K; Schaefer M
    J Biol Chem; 2007 Mar; 282(10):7145-53. PubMed ID: 17218316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five hTRPA1 Agonists Found in Indigenous Korean Mint, Agastache rugosa.
    Moon H; Kim MJ; Son HJ; Kweon HJ; Kim JT; Kim Y; Shim J; Suh BC; Rhyu MR
    PLoS One; 2015; 10(5):e0127060. PubMed ID: 25978436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.